Started by Prosecutor Ray Grogan, the program allows low-level felony drug offenders the opportunity for a second chance at life through treatment and counseling.
Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...
The state government on Friday sought to silence doubters to claim that the Drug Reduction Elimination & Action Mission ...
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
A participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
Financially, UroGen has a market cap of $464mn and a cash runway of 8-9 quarters, despite facing patent challenges from Teva.
It is believed around 1,700 people could be eligible for the treatment, while the NHS estimates around 50 people a year will ...
For 25 years, 45-year-old Tony Serio was in active addiction. Today, he's successful and has been in recovery for eight years ...
Net sales grew +12% (cc 1, +11% USD) with core operating income 1 up +22% (cc, +19% USD) Sales growth driven by continued st ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback